Adina Vultur

Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K

Jessie Villanueva, Adina Vultur, John Tayu Lee et al. · Cancer Cell · 2010 · 1.2K citations · Full text

Medicine, Receptor Tyrosine Kinase, Melanoma +6

A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth

Alexander Roesch, Mizuho Fukunaga‐Kalabis, E C Schmidt et al. · Cell · 2010 · 1.2K citations · Full text

Temporarily Distinct Subpopulation, Slow-cycling Melanoma Cells, Skin Cancer +12

Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells

Alexander Roesch, Adina Vultur, Ivan Bogeski et al. · Cancer Cell · 2013 · 662 citations · Full text

Mitochondrial Respiratory Chain, Tumor Biology, Intrinsic Multidrug Resistance +11

Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2

Michael P. O’Connell, Katie Marchbank, Marie R. Webster et al. · Cancer Discovery · 2013 · 225 citations · Full text

Concurrent MEK2 Mutation and BRAF Amplification Confer Resistance to BRAF and MEK Inhibitors in Melanoma

Jessie Villanueva, Jeffrey R. Infante, Clemens Krepler et al. · Cell Reports · 2013 · 180 citations · Full text